Center for U.S. Policy
  • About
  • Issues
  • Initiatives
  • Events
  • Media
  • Internships
  • About
  • Issues
  • Initiatives
  • Events
  • Media
  • Internships
Category

Substance Misuse

Federal Gov’t Expands Access to Buprenorphine for OUD

Federal Gov’t Expands Access to Buprenorphine for OUD

News January 14, 2021
Marijuana Laws & Lessons to Inform North Carolina Policy

Marijuana Laws & Lessons to Inform North Carolina Policy

CUSP Research January 7, 2021
Pregnant Women Face Barriers to OUD Treatment

Pregnant Women Face Barriers to OUD Treatment

News January 5, 2021
Businesses Display ‘Naloxone Found Here’ Signs

Businesses Display ‘Naloxone Found Here’ Signs

News January 3, 2021
Input to DEA on Injectable Buprenorphine Rules

Input to DEA on Injectable Buprenorphine Rules

CUSP Research December 29, 2020
Drug Poisoning Deaths Reach Highest Levels Ever

Drug Poisoning Deaths Reach Highest Levels Ever

News December 17, 2020
Input to Biden-Harris Transition Team

Input to Biden-Harris Transition Team

CUSP Research December 14, 2020
CBD: Q&A for Substance Misuse Prevention Professionals

CBD: Q&A for Substance Misuse Prevention Professionals

CUSP Research December 11, 2020
DEA Supercharges Patient, Prescriber, Pharmacist Surveillance

DEA Supercharges Patient, Prescriber, Pharmacist Surveillance

News November 9, 2020
DATA 2000 Stymies Access for Black Patients

DATA 2000 Stymies Access for Black Patients

News October 23, 2020
Payer Strategies to Ensure Access to OUD Treatment

Payer Strategies to Ensure Access to OUD Treatment

External Report October 21, 2020
Stigma Against OUD Medications Persists

Stigma Against OUD Medications Persists

External Report October 20, 2020
Loading...
« Previous
Print page

© 2025 Center for U.S. Policy. All Rights Reserved.